ITMCTR1900002474
Not yet recruiting
未知
Chronic prostatitis (qi and blood stasis) application research of traditional Chinese medicine external treatment scheme
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine0 sitesTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Those who meet the Western diagnostic criteria for chronic non\-bacterial prostatitis;
- •(2\) Those who meet the syndrome of qi stagnation and blood stasis syndrome;
- •(3\) Aged 18 to 50 years old;
- •(4\) signed informed consent.
Exclusion Criteria
- •(1\) patients with severe neural tuberculosis, urethral stricture, prostate tumors;
- •(2\) allergic constitution and allergy to various drugs;
- •(3\) combined with severe cardiovascular disease, cerebrovascular disease, liver and kidney dysfunction, hematopoietic system disease, Neuropathy patients;
- •(4\) with urethritis, acute prostatitis, urinary stones and other diseases.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Non Interventional Study of Levofloxacin in Chronic ProstatitisChronic ProstatitisNCT02711943Dr. Reddy's Laboratories Limited500
Not yet recruiting
Not Applicable
Surgical therapy for chronic prostatitis - prospective observational studychronic prostatitisN41.1Chronic prostatitisDRKS00013747niversitätsklinikum Freiburg100
Not yet recruiting
Phase 1
A real world study on the treatment of prostate cancer by integrated Chinese and Western medicineProstate cancerITMCTR2200006847Guangdong Provincial Hospital of Chinese Medicine
Recruiting
Not Applicable
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancerJPRN-UMIN000019278Kyoto University2,000
Recruiting
Not Applicable
A decision aid for the treatment of Benign Prostatic HyperplasiaDA BPHNL-OMON27217200